JPT Technologies Adopts Arrayjet Arrayer for Peptide Chip Production | GenomeWeb

Arrayjet recently installed a customized version of its Ultra Marathon microarrayer instrument at JPT Technologies.

Berlin-based JPT, a subsidiary of BioNTech, will use the Ultra Marathon to print its PepStar peptide microarrays for use in vaccine and immunotherapy development, as well as diagnostics, according to CEO Holger Wenschuh.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.